| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.1M | +19.0% |
| R&D Expense | $0 | — |
| SG&A Expense | $1.3M | +23.5% |
| Operating Income | -$2.1M | -182.4% |
| Interest Expense | $806K | +9.1% |
| Net Income | -$2.6M | -608.0% |
| EPS (Basic) | -$0.04 | -500.0% |
| EPS (Diluted) | -$0.04 | -500.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22K | -88.6% |
| Accounts Receivable | $641K | +19.4% |
| Inventory | $9K | -95.3% |
| Current Assets | $896K | -14.0% |
| Total Assets | $1.6M | -26.5% |
| Current Liabilities | $10.5M | +22.9% |
| Long-term Debt | $5.9M | -13.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.0M | +33.8% |
| Capital Expenditures | $18K | +513.3% |
| Investing Cash Flow | -$8K | -104.4% |
| Financing Cash Flow | $865K | -42.3% |
| Free Cash Flow | -$1.0M | +32.8% |
| Total Liabilities |
| $12.6M |
| +20.3% |
| Stockholders' Equity | -$9.0M | -41.7% |